{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:21:31Z","timestamp":1791451291417,"version":"4.3.3"},"reference-count":149,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.it.2025.04.002","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T13:16:25Z","timestamp":1746623785000},"page":"455-470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Poxvirus structural biology for application to vaccine design"],"prefix":"10.1016","volume":"46","author":[{"given":"Huibin","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Resch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2154-8564","authenticated-orcid":false,"given":"Bernard","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2025.04.002_bb0005","series-title":"Fields Virology (7th edn, Vol. 2): DNA Viruses","first-page":"614","article-title":"Poxviruses","author":"Satheshkumar","year":"2021"},{"key":"10.1016\/j.it.2025.04.002_bb0010","first-page":"165","article-title":"Human monkeypox, 1970\u201379","volume":"58","author":"Breman","year":"1980","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.it.2025.04.002_bb0015","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(24)02353-5","article-title":"Concurrent outbreaks of mpox in Africa \u2013 an update","volume":"405","author":"Beiras","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.it.2025.04.002_bb0020","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.tips.2024.10.015","article-title":"Poxvirus vaccines: the evolution of an 18th-century vaccine to the 21st century","volume":"45","author":"Xiao","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.it.2025.04.002_bb0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-065X.2010.00975.x","article-title":"Smallpox vaccines: targets of protective immunity","volume":"239","author":"Moss","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.it.2025.04.002_bb0030","doi-asserted-by":"crossref","first-page":"734","DOI":"10.15585\/mmwr.mm7122e1","article-title":"Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: recommendations of the Advisory Committee on Immunization Practices \u2013 United States, 2022","volume":"71","author":"Rao","year":"2022","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.it.2025.04.002_bb0035","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1056\/NEJMoa2215201","article-title":"Vaccine effectiveness of JYNNEOS against mpox disease in the United States","volume":"388","author":"Deputy","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2025.04.002_bb0040","first-page":"8","article-title":"Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023","volume":"29","author":"Leeuwen","year":"2024","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.it.2025.04.002_bb0045","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaf074","article-title":"LC16m8 for pre-exposure prophylaxis against mpox in a high-risk population: an open-label randomized trial","author":"Okumura","year":"2025","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.it.2025.04.002_bb0050","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.icb.7100118","article-title":"Correlates of protective immunity in poxvirus infection: where does antibody stand?","volume":"86","author":"Panchanathan","year":"2008","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.it.2025.04.002_bb0055","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/infdis\/jiab111","article-title":"Human antibody responses following vaccinia immunization using protein microarrays and correlation with cell-mediated immunity and antibody-dependent cellular cytotoxicity responses","volume":"224","author":"Frey","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.it.2025.04.002_bb0060","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1128\/JVI.02244-07","article-title":"Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine","volume":"82","author":"Benhnia","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0065","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1073\/pnas.0601025103","article-title":"Ligand-induced and non-fusogenic dissolution of a viral membrane","volume":"103","author":"Law","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2025.04.002_bb0070","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1006\/viro.1996.0142","article-title":"Extracellular enveloped vaccinia virus escapes neutralization","volume":"217","author":"Ichihashi","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.it.2025.04.002_bb0075","series-title":"Fields Virology (7th edn, Vol. 2): DNA Viruses","first-page":"573","article-title":"Poxviridae: the viruses and their replication","author":"Moss","year":"2021"},{"key":"10.1016\/j.it.2025.04.002_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007002","article-title":"Origin of the poxviral membrane: a 50-year-old riddle","volume":"14","author":"Moss","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2025.04.002_bb0085","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1128\/JVI.79.21.13454-13462.2005","article-title":"Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge","volume":"79","author":"Lustig","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0042-6822(90)90294-2","article-title":"The complete DNA sequence of vaccinia virus","volume":"179","author":"Goebel","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.it.2025.04.002_bb0095","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01495-21","article-title":"Ancient gene capture and recent gene loss shape the evolution of orthopoxvirus\u2013host interaction genes","volume":"12","author":"Senkevich","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.it.2025.04.002_bb0100","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1128\/JVI.02302-06","article-title":"Vaccinia virus 4c (A26L) protein on intracellular mature virus binds to the extracellular cellular matrix laminin","volume":"81","author":"Chiu","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0105","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1128\/JVI.06081-11","article-title":"Vaccinia mature virus fusion regulator A26 protein binds to A16 and G9 proteins of the viral entry fusion complex and dissociates from mature virions at low pH","volume":"86","author":"Chang","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007826","article-title":"Vaccinia viral A26 protein is a fusion suppressor of mature virus and triggers membrane fusion through conformational change at low pH","volume":"15","author":"Chang","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2025.04.002_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003563","article-title":"Crystal structure of vaccinia viral A27 protein reveals a structure critical for its function and complex formation with protein","volume":"9","author":"Chang","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2025.04.002_bb0120","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1128\/JVI.02878-15","article-title":"Linear epitopes in vaccinia virus A27 are targets of protective antibodies induced by vaccination against smallpox","volume":"90","author":"Kaever","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0125","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1128\/JVI.00568-08","article-title":"Disparity between in vitro neutralization of vaccinia virus by antibody to the A27 protein and protection of mice to intranasal challenge","volume":"82","author":"Fogg","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0130","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1016\/j.vaccine.2020.07.018","article-title":"Short-term and longer-term protective immune responses generated by subunit vaccination with smallpox A33, B5, L1 or A27 proteins adjuvanted with aluminum hydroxide and CpG in mice challenged with vaccinia virus","volume":"38","author":"Xiao","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.it.2025.04.002_bb0135","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1016\/j.vaccine.2010.07.030","article-title":"A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge","volume":"28","author":"Buchman","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.it.2025.04.002_bb0140","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.1128\/JVI.73.10.8750-8761.1999","article-title":"Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells","volume":"73","author":"Hsiao","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004495","article-title":"Murine anti-vaccinia virus D8 antibodies target different epitopes and differ in their ability to block D8 binding to CS-E","volume":"10","author":"Matho","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2025.04.002_bb0150","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1074\/jbc.M117.814541","article-title":"Structure\u2013function characterization of three human antibodies targeting the vaccinia virus adhesion molecule D8","volume":"293","author":"Matho","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2025.04.002_bb0155","doi-asserted-by":"crossref","first-page":"8050","DOI":"10.1128\/JVI.00836-12","article-title":"Structural and biochemical characterization of the vaccinia virus envelope protein D8 and its recognition by the antibody LA5","volume":"86","author":"Matho","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0160","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1128\/JVI.74.7.3353-3365.2000","article-title":"Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo","volume":"74","author":"Lin","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0165","doi-asserted-by":"crossref","first-page":"7518","DOI":"10.1128\/JVI.74.16.7518-7528.2000","article-title":"Effects of deletion or stringent repression of the H3L envelope gene on vaccinia virus replication","volume":"74","author":"da Fonseca","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0170","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1128\/JVI.02933-15","article-title":"The vaccinia virus H3 envelope protein, a major target of neutralizing antibodies, exhibits a glycosyltransferase fold and binds UDP-Glucose","volume":"90","author":"Singh","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0175","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1128\/JVI.79.18.11724-11733.2005","article-title":"Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice","volume":"79","author":"Davies","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0180","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3390\/v14061224","article-title":"New p35 (H3L) epitope involved in vaccinia virus neutralization and its deimmunization","volume":"14","author":"Khlusevich","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.it.2025.04.002_bb0185","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.semcdb.2016.07.015","article-title":"Membrane fusion during poxvirus entry","volume":"60","author":"Moss","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.it.2025.04.002_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002446","article-title":"The membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell components","volume":"7","author":"Laliberte","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2025.04.002_bb0195","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.1073\/pnas.062163799","article-title":"Complete pathway for protein disulfide bond formation encoded by poxviruses","volume":"99","author":"Senkevich","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2025.04.002_bb0200","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.04.002_bb0205","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.virol.2008.08.009","article-title":"Vaccinia virus entry\/fusion complex subunit A28 is a target of neutralizing and protective antibodies","volume":"380","author":"Nelson","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.it.2025.04.002_bb0210","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions","volume":"78","author":"Fogg","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0215","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.0501103102","article-title":"The 1.51-A structure of the poxvirus L1 protein, a target of potent neutralizing antibodies","volume":"102","author":"Su","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2025.04.002_bb0220","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.virol.2007.06.042","article-title":"Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein","volume":"368","author":"Su","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.it.2025.04.002_bb0225","doi-asserted-by":"crossref","first-page":"16807","DOI":"10.1038\/s41598-018-34244-7","article-title":"The 2.1 angstrom structure of protein F9 and its comparison to L1, two components of the conserved poxvirus entry-fusion complex","volume":"8","author":"Diesterbeck","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.it.2025.04.002_bb0230","doi-asserted-by":"crossref","first-page":"9455","DOI":"10.1128\/JVI.01149-06","article-title":"Vaccinia virus F9 virion membrane protein is required for entry but not virus assembly, in contrast to the related l1 protein","volume":"80","author":"Brown","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0235","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1128\/JVI.00162-08","article-title":"Vaccinia virus A56\/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complex","volume":"82","author":"Wagenaar","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0240","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2179351","article-title":"Structural basis of poxvirus A16\/G9 binding for sub-complex formation","volume":"12","author":"Yang","year":"2023","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.it.2025.04.002_bb0245","doi-asserted-by":"crossref","first-page":"18572","DOI":"10.1073\/pnas.0509239102","article-title":"Poxvirus multiprotein entry-fusion complex","volume":"102","author":"Senkevich","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2025.04.002_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011500","article-title":"Structural and functional analysis of vaccinia viral fusion complex component protein A28 through NMR and molecular dynamic simulations","volume":"19","author":"Kao","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2025.04.002_bb0255","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.virol.2010.05.025","article-title":"The neutralizing antibody response to the vaccinia virus A28 protein is specifically enhanced by its association with the H2 protein","volume":"405","author":"Shinoda","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.it.2025.04.002_bb0260","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01343-23","article-title":"Structural and functional analyses of viral H2 protein of the vaccinia virus entry fusion complex","volume":"97","author":"Kao","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0265","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1128\/JVI.00434-08","article-title":"A conserved sequence within the H2 subunit of the vaccinia virus entry\/fusion complex is important for interaction with the A28 subunit and infectivity","volume":"82","author":"Nelson","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0270","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2022.2160661","article-title":"Crystal structure of vaccinia virus G3\/L5 sub-complex reveals a novel fold with extended inter-molecule interactions conserved among orthopoxviruses","volume":"12","author":"Lin","year":"2023","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.it.2025.04.002_bb0275","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1128\/JVI.79.15.9458-9469.2005","article-title":"Vaccinia virus A21 virion membrane protein is required for cell entry and fusion","volume":"79","author":"Townsley","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2025.169097","article-title":"The 2.3 \u00c5 structure of A21, a protein component of the conserved poxvirus entry-fusion complex","volume":"437","author":"Diesterbeck","year":"2025","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.it.2025.04.002_bb0285","doi-asserted-by":"crossref","first-page":"12822","DOI":"10.1128\/JVI.01744-09","article-title":"Characterization of a newly Identified 35 amino acid component of the vaccinia virus entry\/fusion complex conserved in all chordopoxviruses","volume":"83","author":"Satheshkumar","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0290","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00852-21","article-title":"Insights into the prganization of the poxvirus multicomponent entry-fusion complex from proximity analyses in living infected cells","volume":"95","author":"Schin","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0295","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.virol.2013.06.003","article-title":"Role of the vaccinia virus O3 protein in cell entry can be fulfilled by its sequence flexible transmembrane domain","volume":"444","author":"Satheshkumar","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.it.2025.04.002_bb0300","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0065-2776(01)77018-6","article-title":"The antiviral activity of antibodies in vitro and in vivo","volume":"77 77","author":"Parren","year":"2001","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.it.2025.04.002_bb0305","doi-asserted-by":"crossref","first-page":"8885","DOI":"10.1128\/JVI.78.16.8885-8901.2004","article-title":"Vaccinia virus morphogenesis: A13 phosphoprotein is required for assembly of mature virions","volume":"78","author":"Unger","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0310","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.virol.2011.06.029","article-title":"An epitope conserved in orthopoxvirus A13 envelope protein is the target of neutralizing and protective antibodies","volume":"418","author":"Xu","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.it.2025.04.002_bb0315","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1128\/jvi.71.3.1821-1833.1997","article-title":"Characterization of early stages in vaccinia virus membrane biogenesis: implications of the 21-kilodalton protein and a newly identified 15-kilodalton envelope protein","volume":"71","author":"Rodriguez","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0320","article-title":"DeepTMHMM predicts alpha and beta transmembrane proteins using deep neural networks","author":"Hallgren","year":"2022","journal-title":"BioRxiv"},{"key":"10.1016\/j.it.2025.04.002_bb0325","doi-asserted-by":"crossref","first-page":"8857","DOI":"10.1128\/JVI.77.16.8857-8871.2003","article-title":"Investigation of structural and functional motifs within the vaccinia virus A14 phosphoprotein, an essential component of the virion membrane","volume":"77","author":"Mercer","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0330","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1128\/jvi.69.8.4640-4648.1995","article-title":"Vaccinia virus A17L gene product is essential for an early step in virion morphogenesis","volume":"69","author":"Rodr\u00edguez","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0335","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1128\/jvi.67.6.3435-3440.1993","article-title":"The vaccinia virus 14-kilodalton fusion protein forms a stable complex with the processed protein encoded by the vaccinia virus A17L gene","volume":"67","author":"Rodriguez","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0340","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1006\/viro.1999.9870","article-title":"Membrane topology of the vaccinia virus A17L envelope protein","volume":"261","author":"Betakova","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.it.2025.04.002_bb0345","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.celrep.2016.01.075","article-title":"Poxviruses encode a reticulon-like protein that promotes membrane curvature","volume":"14","author":"Erlandson","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.it.2025.04.002_bb0350","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/viro.2001.1131","article-title":"The A17L gene product of vaccinia virus is exposed on the surface of IMV","volume":"290","author":"Wallengren","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.it.2025.04.002_bb0355","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/JVI.75.1.303-310.2001","article-title":"The vaccinia virus A33R protein provides a chaperone function for viral membrane localization and tyrosine phosphorylation of the A36R protein","volume":"75","author":"Wolffe","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0360","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1126\/science.1183173","article-title":"Repulsion of superinfecting virions: A mechanism for rapid virus spread","volume":"327","author":"Doceul","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.it.2025.04.002_bb0365","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"Galmiche","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.it.2025.04.002_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005148","article-title":"Structural and functional characterization of anti-A33 antibodies reveal a potent cross-species orthopoxviruses neutralizer","volume":"11","author":"Matho","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2025.04.002_bb0375","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.virol.2004.07.024","article-title":"Synergistic neutralizing activities of antibodies to outer membrane proteins of the two infectious forms of vaccinia virus in the presence of complement","volume":"328","author":"Lustig","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.it.2025.04.002_bb0380","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.virol.2008.04.003","article-title":"Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine","volume":"377","author":"Golden","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.it.2025.04.002_bb0385","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/1743-422X-10-229","article-title":"Active vaccination with vaccinia virus A33 protects mice vaccinia and ectromelia viruses but not against cowpoxvirus; of the specific adaptive immune response","volume":"10","author":"Paran","year":"2013","journal-title":"Virol. J."},{"key":"10.1016\/j.it.2025.04.002_bb0390","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1128\/JVI.02247-09","article-title":"The structure of the poxvirus A33 protein reveals a dimer of unique C-type lectin-like domains","volume":"84","author":"Su","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0395","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01343-18","article-title":"The ectodomain of the vaccinia virus glycoprotein A34 is required for cell binding by extracellular virions and contains a large region capable of interaction with glycoprotein B5","volume":"93","author":"Monticelli","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0400","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1128\/jvi.67.6.3319-3325.1993","article-title":"Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene","volume":"67","author":"Blasco","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0405","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1099\/vir.0.030460-0","article-title":"The vaccinia virus A56 protein: a multifunctional transmembrane glycoprotein that anchors two secreted viral proteins","volume":"92","author":"DeHaven","year":"2011","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0410","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.virol.2004.05.004","article-title":"Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin","volume":"325","author":"Bell","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.it.2025.04.002_bb0415","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/nm1457","article-title":"Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination","volume":"12","author":"Putz","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2025.04.002_bb0420","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1128\/JVI.01797-08","article-title":"Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement","volume":"83","author":"Benhnia","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0425","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1128\/JVI.79.10.6260-6271.2005","article-title":"Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R","volume":"79","author":"Aldaz-Carroll","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0430","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1038\/s41467-024-48312-2","article-title":"Two noncompeting human neutralizing antibodies targeting MPXV B6 show protective effects against orthopoxvirus infections","volume":"15","author":"Zhao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2025.04.002_bb0435","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1128\/jvi.65.11.5910-5920.1991","article-title":"Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000 Dalton outer envelope protein","volume":"65","author":"Blasco","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0440","doi-asserted-by":"crossref","first-page":"32042","DOI":"10.1074\/jbc.272.51.32042","article-title":"Lipase activities of p37, the major envelope protein of vaccinia virus","volume":"272","author":"Baek","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2025.04.002_bb0445","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.virol.2008.07.020","article-title":"The vaccinia virus fusion inhibitor proteins SPI-3 (K2) and HA (A56) expressed by infected cells reduce the entry of superinfecting virus","volume":"380","author":"Turner","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.it.2025.04.002_bb0450","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1099\/0022-1317-13-1-19","article-title":"Inactivated smallpox vaccine: immunogenicity of inactivated intracellular and extracellular vaccinia virus","volume":"13","author":"Turner","year":"1971","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0455","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1099\/0022-1317-72-5-1031","article-title":"Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence","volume":"72","author":"Meyer","year":"1991","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0460","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","article-title":"Nonreplicating vaccinia vector efficiently expresses recombinant genes","volume":"89","author":"Sutter","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2025.04.002_bb0465","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.04.002_bb0470","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jama.2009.289","article-title":"Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8","volume":"301","author":"Saito","year":"2009","journal-title":"J. Amer. Med. Assoc."},{"key":"10.1016\/j.it.2025.04.002_bb0475","doi-asserted-by":"crossref","first-page":"11873","DOI":"10.1128\/JVI.79.18.11873-11891.2005","article-title":"An attenuated LC16m8 smallpox vaccine: Analysis of full-genome sequence and induction of immune protection","volume":"79","author":"Morikawa","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0480","doi-asserted-by":"crossref","first-page":"408","DOI":"10.7883\/yoken.JJID.2016.417","article-title":"A single vaccination of nonhuman primates with highly attenuated smallpox vaccine, LC16m8, provides long-term protection against monkeypox","volume":"70","author":"Iizuka","year":"2017","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.it.2025.04.002_bb0485","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.vaccine.2006.10.009","article-title":"A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost","volume":"25","author":"Xiao","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.it.2025.04.002_bb0490","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.it.2025.04.002_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042353","article-title":"Side-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primates","volume":"7","author":"Golden","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.it.2025.04.002_bb0500","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg3540","article-title":"An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge","volume":"15","author":"Freyn","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.it.2025.04.002_bb0505","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1038\/s41467-023-41628-5","article-title":"mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge","volume":"14","author":"Hou","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2025.04.002_bb0510","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41392-023-01432-5","article-title":"Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus","volume":"8","author":"Sang","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.it.2025.04.002_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105974","article-title":"An mpox quadrivalent mRNA vaccine protects mice from lethal vaccinia virus challenge","volume":"230","author":"Li","year":"2024","journal-title":"Antivir. Res."},{"key":"10.1016\/j.it.2025.04.002_bb0520","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.cell.2024.01.017","article-title":"A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease","volume":"187","author":"Zuiani","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.it.2025.04.002_bb0525","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41541-024-01052-2","article-title":"Mpox mRNA-1769 vaccine inhibits orthopoxvirus replication at intranasal, intrarectal, and cutaneous sites of inoculation","volume":"9","author":"Cotter","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.it.2025.04.002_bb0530","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1016\/j.cell.2024.08.043","article-title":"Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates","volume":"187","author":"Mucker","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.it.2025.04.002_bb0535","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.it.2025.04.002_bb0540","doi-asserted-by":"crossref","first-page":"14A.3.1","DOI":"10.1002\/9780471729259.mc14a03s39","article-title":"Preparation of cell cultures and vaccinia virus stocks","volume":"39","author":"Cotter","year":"2015","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.it.2025.04.002_bb0545","doi-asserted-by":"crossref","first-page":"10684","DOI":"10.1128\/JVI.77.19.10684-10688.2003","article-title":"Development and use of a vaccinia virus neutralization assay based on flow cytometric detection of green fluorescent protein","volume":"77","author":"Earl","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0550","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1086\/376557","article-title":"Development of a novel vaccinia-neutralization assay based on reporter-gene expression","volume":"188","author":"Manischewitz","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.it.2025.04.002_bb0555","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.chom.2023.05.001","article-title":"Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals","volume":"31","author":"Hubert","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.it.2025.04.002_bb0560","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1099\/0022-1317-13-1-9","article-title":"An antigenic difference between intracellular and extracellular rabbitpox virus","volume":"13","author":"Appleyard","year":"1971","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0565","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1006\/viro.2002.1608","article-title":"Expression of the vaccinia virus A2.5L redox protein Is required for virion morphogenesis","volume":"300","author":"Senkevich","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.it.2025.04.002_bb0570","doi-asserted-by":"crossref","first-page":"12068","DOI":"10.1073\/pnas.210397997","article-title":"A viral member of the ERV1\/ALR protein family participates in a cytoplasmic pathway of disulfide bond formation","volume":"97","author":"Senkevich","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2025.04.002_bb0575","doi-asserted-by":"crossref","first-page":"7706","DOI":"10.1128\/JVI.00521-06","article-title":"The structure of G4, the poxvirus disulfide oxidoreductase essential for virus maturation and infectivity","volume":"80","author":"Su","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0580","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.jmb.2006.11.002","article-title":"Crystal structures of a poxviral glutaredoxin in the oxidized and reduced states show redox-correlated structural changes","volume":"365","author":"Bacik","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.it.2025.04.002_bb0585","doi-asserted-by":"crossref","first-page":"9701","DOI":"10.1128\/JVI.74.20.9701-9711.2000","article-title":"The vaccinia virus A9L gene encodes a membrane protein required for an early step in virion morphogenesis","volume":"74","author":"Yeh","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0590","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1128\/JVI.02529-12","article-title":"Biogenesis of the vaccinia virus membrane: genetic and ultrastructural analysis of the contributions of the A14 and A17 proteins","volume":"87","author":"Unger","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0595","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00558-17","article-title":"Deletion of the vaccinia virus I2 vrotein interrupts virion morphogenesis leading to retention of the scaffold protein and mislocalization of membrane-associated entry proteins","volume":"91","author":"Hyun","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0600","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1128\/JVI.74.9.4085-4092.2000","article-title":"Vaccinia virus A14.5L gene encodes a hydrophobic 53-amino acid virion membrane protein that enhances virulence in mice and is conserved amongst vertebrate poxviruses","volume":"74","author":"Betakova","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0605","doi-asserted-by":"crossref","first-page":"10079","DOI":"10.1128\/JVI.00816-08","article-title":"Vaccinia virus WR53.5\/F14.5 protein is a new component of intracellular mature virus and is important for calcium-independent cell adhesion and vaccinia virus virulence in mice","volume":"82","author":"Ismailia","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0610","doi-asserted-by":"crossref","first-page":"10071","DOI":"10.1128\/JVI.01355-08","article-title":"Vaccinia virus encodes a small hydrophobic virion membrane protein (I5) that enhances replication and virulence in mice","volume":"82","author":"Sood","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0615","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1128\/JVI.73.4.2863-2875.1999","article-title":"Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation","volume":"73","author":"Rottger","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0620","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1128\/JVI.74.8.3771-3780.2000","article-title":"Golgi network targeting and plasma membrane internalization signals in vaccinia virus B5R envelope protein","volume":"74","author":"Ward","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0625","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/viro.1995.1542","article-title":"Biochemical analysis of the major vaccinia virus envelope antigen","volume":"213","author":"Schmutz","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.it.2025.04.002_bb0630","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1128\/JVI.01684-08","article-title":"Expression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion","volume":"83","author":"Wagenaar","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0635","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4792","article-title":"UCSF Chimera: tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci."},{"key":"10.1016\/j.it.2025.04.002_bb0640","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/0300985810378649","article-title":"Animal models of orthopoxvirus infection","volume":"47","author":"Chapman","year":"2010","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.it.2025.04.002_bb0645","series-title":"Biosafety in Microbiological and Biomedical Laboratories","year":"2020"},{"key":"10.1016\/j.it.2025.04.002_bb0650","doi-asserted-by":"crossref","first-page":"15196","DOI":"10.1073\/pnas.0405954101","article-title":"Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox","volume":"101","author":"Jahrling","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2025.04.002_bb0655","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009633","article-title":"Teaching a new mouse old tricks: humanized mice as an infection model for variola virus","volume":"17","author":"Hutson","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2025.04.002_bb0660","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2217\/fvl.12.130","article-title":"A review of experimental and natural infections of animals with monkeypox virus between 1958 and 2012","volume":"8","author":"Parker","year":"2013","journal-title":"Future Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0665","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.imj.2023.05.004","article-title":"Animal models of mpox virus infection and disease","volume":"2","author":"Wei","year":"2023","journal-title":"Infect. Med. (Beijing)"},{"key":"10.1016\/j.it.2025.04.002_bb0670","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/BF01249641","article-title":"Studies on the pathogenesis of monkey pox. II. Dose-response and virus dispersion","volume":"27","author":"Wenner","year":"1969","journal-title":"Arch. Gesamte Virusforsch"},{"key":"10.1016\/j.it.2025.04.002_bb0675","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF01249642","article-title":"Studies on the pathogenesis of monkey pox. 3. Histopathological lesions and sites of immunofluorescence","volume":"27","author":"Wenner","year":"1969","journal-title":"Arch. Gesamte Virusforsch"},{"key":"10.1016\/j.it.2025.04.002_bb0680","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1038\/labinvest.3780373","article-title":"The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis)","volume":"81","author":"Zaucha","year":"2001","journal-title":"Lab. Investig."},{"key":"10.1016\/j.it.2025.04.002_bb0685","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1128\/JVI.01931-10","article-title":"Comparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route","volume":"85","author":"Johnson","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0690","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.virol.2005.05.030","article-title":"Virulence differences between monkeypox virus isolates from West Africa and the Congo basin","volume":"340","author":"Chen","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.it.2025.04.002_bb0695","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1099\/vir.0.010207-0","article-title":"Virulence and pathophysiology of the Congo Basin and West African strains of monkeypox virus in non-human primates","volume":"90","author":"Saijo","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0700","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2332669","article-title":"Mpox virus clade IIb infected Cynomolgus macaques via mimic natural infection routes closely resembled human mpox infection","volume":"13","author":"Li","year":"2024","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.it.2025.04.002_bb0705","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.virol.2008.09.025","article-title":"Experimental infection of an African dormouse (Graphiurus kelleni) with monkeypox virus","volume":"383","author":"Schultz","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.it.2025.04.002_bb0710","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3201\/eid1003.030878","article-title":"Monkeypox transmission and pathogenesis in prairie dogs","volume":"10","author":"Guarner","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.it.2025.04.002_bb0715","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1354\/vp.41-6-702","article-title":"Extensive lesions of monkeypox in a prairie dog (Cynomys sp.)","volume":"41","author":"Langohr","year":"2004","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.it.2025.04.002_bb0720","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/965710","article-title":"Comparison of monkeypox virus clade kinetics and pathology within the prairie dog animal model using a serial sacrifice study design","volume":"2015","author":"Hutson","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.it.2025.04.002_bb0725","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3201\/eid1009.040310","article-title":"Experimental infection of ground squirrels (Spermophilius tridecemlineatus) with monkeypox virus","volume":"10","author":"Tesh","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.it.2025.04.002_bb0730","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.1128\/JVI.00621-10","article-title":"Identification of wild-derived inbred mouse strains highly susceptible to monkeypox virus infection for use as small animal models","volume":"84","author":"Americo","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2025.04.002_bb0735","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008505","article-title":"Natural killer cells expanded in vivo or ex vivo with IL-15 overcomes the inherent susceptibility of CAST mice to lethal infection with orthopoxviruses","volume":"16","author":"Earl","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2025.04.002_bb0740","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2220415120","article-title":"Virulence differences of mpox (monkeypox) virus clades I, IIa, and IIb.1 in a small animal model","volume":"120","author":"Americo","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2025.04.002_bb0745","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2025.2456144","article-title":"A functional approach to analyze the genetic basis for differences in virulence of monkeypox virus clades","volume":"14","author":"Earl","year":"2025","journal-title":"Emerg. Microbes Infect."}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490625000948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490625000948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T14:54:25Z","timestamp":1749740065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490625000948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":149,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1471490625000948"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2025.04.002","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Poxvirus structural biology for application to vaccine design","name":"articletitle","label":"Article Title"},{"value":"Trends in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.it.2025.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}